138 related articles for article (PubMed ID: 187099)
1. Immunotherapy with nonviable microbial components.
Ribi E; Milner KC; Granger DL; Kelly MT; Yamamoto K; Brehmer W; Parker R; Smith RF; Strain SM
Ann N Y Acad Sci; 1976; 277(00):228-38. PubMed ID: 187099
[TBL] [Abstract][Full Text] [Related]
2. Tumor regression caused by endotoxins and mycobacterial fractions.
Ribi EE; Granger DL; Milner KC; Strain SM
J Natl Cancer Inst; 1975 Nov; 55(5):1253-7. PubMed ID: 173865
[TBL] [Abstract][Full Text] [Related]
3. Biologically active components from mycobacterial cell walls. II. Suppression and regression of strain-2 guinea pig hepatoma.
Meyer TJ; Ribi EE; Azuma I; Zbar B
J Natl Cancer Inst; 1974 Jan; 52(1):103-11. PubMed ID: 4359409
[No Abstract] [Full Text] [Related]
4. Immunotherapy of cancer: tumor suppression and regression by cell walls of Mycobacterium phlei attached to oil droplets.
Gray GR; Ribi E; Granger D; Parker R; Azuma I; Yamamoto K
J Natl Cancer Inst; 1975 Sep; 55(3):727-30. PubMed ID: 1159851
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy of guinea pig cancer with BCG.
Zbar B; Rapp HJ
Cancer; 1974 Oct; 34(4 Suppl):suppl:1532-40. PubMed ID: 4371315
[No Abstract] [Full Text] [Related]
6. Immunotherapy of cancer: regression of established intradermal tumors after intralesional injection of mycobacterial cell walls attached to oil droplets.
Zbar B; Ribi E; Meyer T; Azuma I; Rapp HJ
J Natl Cancer Inst; 1974 May; 52(5):1571-7. PubMed ID: 4364736
[No Abstract] [Full Text] [Related]
7. Immunotherapy and vaccination against cancer with non-living BCG and cord factor (trehalose-6,6'-dimycolate).
Bekierkunst A
Int J Cancer; 1975 Sep; 16(3):442-7. PubMed ID: 170221
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy of experimental cancer by intralesional injection of emulsified nonliving mycobacteria: comparison of Mycobacterium bovis (BCG), Mycobacterium phlei, and Mycobacterium smegmatis.
Yarkoni E; Rapp HJ
Infect Immun; 1980 Jun; 28(3):887-92. PubMed ID: 6995326
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of bacterial infection. II. effect of Listeria monocytogenes on growth of a guinea pig hepatoma.
Bast RC; Zbar B; Miller TE; Mackaness GB; Rapp HJ
J Natl Cancer Inst; 1975 Mar; 54(3):757-61. PubMed ID: 164568
[TBL] [Abstract][Full Text] [Related]
10. Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. IV. Development of immunity to tumor cells and BCG.
Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
J Natl Cancer Inst; 1973 Dec; 51(6):1897-908. PubMed ID: 4358147
[No Abstract] [Full Text] [Related]
11. Intratumor chemoimmunotherapy with mitomycin C and components from mycobacteria in regression of line 10 tumors in guinea pigs.
McLaughlin CA; Cantrell JL; Ribi E; Goldberg EP
Cancer Res; 1978 May; 38(5):1311-6. PubMed ID: 205361
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy of guinea pigs with dermal and visceral tumor implants: comparison of living and nonliving BCG.
Yarkoni E; Peters L; Rapp HJ; Hanna MG; Hunter JT
Infect Immun; 1979 May; 24(2):565-66. PubMed ID: 378859
[TBL] [Abstract][Full Text] [Related]
13. Tumor regression after intralesional injection of emulsified trehalose-6,6'-dimycolate (cord factor): efficacy increases with oil concentration.
Yarkoni E; Meltzer MS; Rapp HJ
Int J Cancer; 1977 Jun; 19(6):818-21. PubMed ID: 326683
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of anti-tumour immunity in guinea-pigs by methanol extraction residue of BCG.
Wainberg MA; Deutsch V; Weiss DW
Br J Cancer; 1976 Nov; 34(5):500-8. PubMed ID: 187207
[TBL] [Abstract][Full Text] [Related]
15. Histopathology of Mycobacterium bovis (BCG)-mediated tumor regression.
Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
Natl Cancer Inst Monogr; 1972 Dec; 35():345-58. PubMed ID: 4349152
[No Abstract] [Full Text] [Related]
16. Detection of complement-dependent antibody to tumor cells in sera of strain-2 guinea pigs cured of their tumors by BCG Treatment.
Boyle MD; Ohanian SH; Borsos T
J Natl Cancer Inst; 1976 Mar; 56(3):623-6. PubMed ID: 176400
[TBL] [Abstract][Full Text] [Related]
17. Synergistic activity of components of mycobacteria and mutant Salmonella in causing regression of line-10 tumors in guinea pigs.
McLaughlin CA; Hargrave SL; Bickel WD; Ribi E
Cancer Res; 1979 May; 39(5):1766-71. PubMed ID: 371795
[No Abstract] [Full Text] [Related]
18. Influence of type of oil and surfactant concentration on the efficacy of emulsified Mycobacterium bovis BCG cell walls to induce tumor regression in guinea pigs.
Yarkoni E; Rapp HJ
Infect Immun; 1980 Jun; 28(3):881-6. PubMed ID: 6995325
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy of guinea pigs with a transplanted hepatoma: comparison of intralesionally injected emulsions containing heat-killed Nocardia rubra, Mycobacterium bovis (BCG) and Mycobacterium phlei.
Yarkoni E; Rapp HJ
Oncology; 1982; 39(5):314-8. PubMed ID: 7099513
[TBL] [Abstract][Full Text] [Related]
20. Tumor suppression by cell walls of mycobacterium bovis attached to oil droplets.
Zbar B; Rapp HJ; Ribi EE
J Natl Cancer Inst; 1972 Mar; 48(3):831-5. PubMed ID: 4333775
[No Abstract] [Full Text] [Related]
[Next] [New Search]
